Shu Yang and Vytrina win Penn Health Tech Award and PCI’s Inventor of the Year Award
In this Penn Today article, Yang explains how her inventions begin with changes on a fundamental level that can then grow into scalable and impactful products.
Robotics Growth in Philadelphia Highlighted
The Philadelphia Business Journal recently released an article about robotics growth in Philadelphia.
Penn Spinout EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD
Penn spinout EpiVario, a biotech company focusing on neuroepigenetics for addiction disorders, has acquired small molecule acetyl co-A synthetase-2 inhibitor (ACSS2i) portfolio.
Four Penn Startups Make The Philadelphia Business Journal’s PHL Inno List of 2024 Startups to Watch
Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.
Penn health system profits support medical research and teaching over past decade
Penn was highlighted in the Philadelphia Inquirer for investing $2 billion in profits from its health system into medical research and physician support over the past decade.
PCI Recognized on Technical.ly’s List of Philadelphia’s Biggest Tech Moments of 2023
In the article, Technical.ly highlights that Penn affiliated startups attracted over $1 billion in investment capital in 2023.
Penn Nobel-Prize Winners Receive Warm Welcome in Sweden
Karikó and Weissman were celebrated at several days of ceremonies and festivities in Sweden, two months after first learning the news.
Serpex Acquired by Maverix Medical
Serpex Medical leverages the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer.
Penn Engineering Researchers Invent Origami-Inspired Microbots
The goal of this innovative technology is to use the microrobots to assist in repairing peripheral nerves.
More than 260,000 Penn Medicine patients have agreed to share their DNA for research via Penn Medicine BioBank
By obtaining samples from a wide-cross section of humanity, researchers are able to cross-reference participants’ DNA with their health records and identify genetic variants for a range of diseases.